These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2497222)

  • 1. Immunoreactive inhibin concentrations in serum throughout the menstrual cycle of the macaque: suppression of inhibin during the luteal phase after treatment with an LHRH antagonist.
    Fraser HM; Robertson DM; De Kretser DM
    J Endocrinol; 1989 Apr; 121(1):R9-12. PubMed ID: 2497222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of progesterone and inhibin secretion during the luteal phase in the macaque.
    Smith KB; Fraser HM
    J Endocrinol; 1991 Jan; 128(1):107-13. PubMed ID: 1900319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of treatment with an LHRH antagonist on the ovulatory cycle are reduced when administered during the late follicular phase.
    Fraser HM
    Contraception; 1990 Jan; 41(1):73-83. PubMed ID: 2105873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides).
    Fraser HM; Abbott M; Laird NC; McNeilly AS; Nestor JJ; Vickery BH
    J Endocrinol; 1986 Oct; 111(1):83-90. PubMed ID: 3097236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of luteal progesterone secretion in the stumptailed macaque by an antagonist analogue of luteinizing hormone releasing hormone.
    Fraser HM; Baird DT; McRae GI; Nestor JJ; Vickery BH
    J Endocrinol; 1985 Feb; 104(2):R1-4. PubMed ID: 3881554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of late follicular phase administration of antide on ovulation and inhibin secretion in macaques.
    Fraser HM; Lunn SF; Cowen GM; Smith KB; Conn PM
    Contraception; 1991 Dec; 44(6):667-76. PubMed ID: 1773623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
    McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
    Fluker MR; Marshall LA; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM; Lunn SF; Morris KD; Deghenghi R
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.
    Suresh PS; Medhamurthy R
    Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin secretion after treatment with an LHRH agonist and subsequent ovarian hyperstimulation induced by FSH in the macaque (Macaca arctoides).
    Fraser HM; Smith KB; Reddi K; Lunn SF
    J Reprod Fertil; 1990 Jul; 89(2):441-6. PubMed ID: 2119427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
    Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion.
    Fraser HM; Tsonis CG
    J Endocrinol; 1994 Jul; 142(1):181-6. PubMed ID: 7964278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immunoreactive inhibin levels during the normal human menstrual cycle.
    McLachlan RI; Robertson DM; Healy DL; Burger HG; de Kretser DM
    J Clin Endocrinol Metab; 1987 Nov; 65(5):954-61. PubMed ID: 3667888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.
    le Nestour E; Marraoui J; Lahlou N; Roger M; de Ziegler D; Bouchard P
    J Clin Endocrinol Metab; 1993 Aug; 77(2):439-42. PubMed ID: 8345049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.